Therefore, they might represent good candidate markers for the identification of the whole population of blood circulating NK-cells, even when CD56 or CD16 are downregulated in reactive conditions (i.e., in response to viral/bacterial infections) (8–13) or in clonal expansions of CD56-/lo NK-cells (15). The gene discussed is NCAM1; the disease is bacterial infectious disease.